Stock Research for AGN

Current Price


Latest Update: 2018-03-16 16:00:00

$ 169.2200
$ 168.9800
$ 168.9900

Featured Broker: TradeStation

Get the due diligence for another stock.


AGN Stock Chart & Research Data

The AGN chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the AGN chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


AGN Due diligence Resources & Stock Charts

The AGN stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View AGN Detailed Price Forecast - CNN Money CNN View AGN Detailed Summary - Google Finance
Yahoo View AGN Detailed Summary - Yahoo! Finance Zacks View AGN Stock Research & Analysis -

Stock Analysis

TradeIdeas View AGN Trends & Analysis - Trade-Ideas Barrons View AGN Major Holders - Barrons
NASDAQ View AGN Call Transcripts - NASDAQ Seeking View AGN Breaking News & Analysis - Seeking Alpha
Spotlight View AGN Annual Report - OTC Report View AGN OTC Short Report -
TradeKing View AGN Fundamentals - TradeKing Charts View AGN SEC Filings - Bar Chart
WSJ View Historical Prices for AGN - The WSJ Morningstar View Performance/Total Return for AGN - Morningstar
MarketWatch View the Analyst Estimates for AGN - MarketWatch CNBC View the Earnings History for AGN - CNBC
StockMarketWatch View the AGN Earnings - StockMarketWatch MacroAxis View AGN Buy or Sell Recommendations - MacroAxis
Bullish View the AGN Bullish Patterns - American Bulls Short Pains View AGN Short Pain Metrics -

Social Media Mentions

StockTwits View AGN Stock Mentions - StockTwits PennyStocks View AGN Stock Mentions - PennyStockTweets
Twitter View AGN Stock Mentions - Twitter Invest Hub View AGN Investment Forum News - Investor Hub
Yahoo View AGN Stock Mentions - Yahoo! Message Board Seeking Alpha View AGN Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for AGN - Insider Cow View Insider Transactions for AGN - Insider Cow
CNBC View AGN Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for AGN - OTC Markets
Yahoo View Insider Transactions for AGN - Yahoo! Finance NASDAQ View Institutional Holdings for AGN - NASDAQ

Stock Charts

FinViz View AGN Stock Insight & Charts - StockCharts View AGN Investment Charts -
BarChart View AGN Stock Overview & Charts - BarChart Trading View View AGN User Generated Charts - Trading View

Latest Financial News for AGN

[$$] Allergan's Stock Is Headed for a Face-Lift
Posted on Friday March 16, 2018

Looks can be deceiving when it comes to the drugmaker Allergan. New competition to its top product, Botox, and the surprise loss of patent exclusivity for its second biggest, the dry-eye treatment Restasis, have left investors with worry lines. The valuation is low enough that most of the bad news surrounding Allergan appear already priced in.

Mylan N.V. Stock Is Headed Back Down to $40
Posted on Thursday March 15, 2018

Drugmaker Mylan N.V. (NASDAQ:MYL) has garnered quite a bit of bullish attention since the beginning of the month. MYL stock is up more than 4% so far in March, beating the benchmark S&P 500 Index’s gain of about 1.4%. First, Mylan reported better than expected earnings on March 1 and it announced a competitor to Allergan plc Ordinary Sharess (NYSE:AGN) Botox treatment.

Allergan Considering All Strategic Options 'With A Sense Of Urgency'
Posted on Thursday March 15, 2018

Allergan plc Ordinary Shares (NYSE: AGN ) continued its two-week, 16-percent rebound Wednesday, and RBC Capital Markets anticipates 28 percent of additional upside . The Rating Analyst Randall Stanicky ...

Allergan CEO: We Are Looking at All Options to Create Shareholder Value
Posted on Thursday March 15, 2018

Brent Saunders spoke at the Barclays healthcare conference, a few weeks after Mylan and Revance Therapeutics said they were teaming up on a proposed biosimilar of Allergan's Botox.

Warning: DOMDocument::load( failed to open stream: HTTP request failed! HTTP/1.0 404 Not Found in /home/allsites/ on line 494

Warning: DOMDocument::load(): I/O warning : failed to load external entity "" in /home/allsites/ on line 494

Enter a stock symbol to view the stock details.